Lowe S W
Cold Spring Harbor Laboratory, New York 11724, USA.
Endocr Relat Cancer. 1999 Mar;6(1):45-8. doi: 10.1677/erc.0.0060045.
p53 is activated by a variety of cellular stresses, including DNA damage, hypoxia, and mitogenic oncogenes, but the extent to which each signal engages p53 as a tumour suppressor remains unknown. In non-immortal cells, the adenovirus E1A oncogene activates p53 to promote apoptosis, whereas oncogenic ras activates p53 to promote cellular senescence. Inactivation of p53 prevents E1A-induced apoptosis or Ras-induced senescence, allowing proliferation to continue unabated. In each instance, the ability of the oncogene to activate p53 involves the same functions as are required for their transforming potential, implying that p53 activation acts as a fail-safe mechanism to counter hyperproliferative signals. Furthermore, p19(ARF) is strictly required for oncogene signalling to p53. The fact that ARF--itself a tumour suppressor--acts as an intermediary in this response argues that the tumour suppressor activity of p53 can arise from its ability to eliminate oncogene-expressing cells.
p53可被多种细胞应激激活,包括DNA损伤、缺氧和有丝分裂原性癌基因,但每种信号将p53作为肿瘤抑制因子激活的程度仍不清楚。在非永生化细胞中,腺病毒E1A癌基因激活p53以促进细胞凋亡,而致癌性Ras激活p53以促进细胞衰老。p53的失活可阻止E1A诱导的细胞凋亡或Ras诱导的衰老,从而使细胞增殖持续不受抑制。在每种情况下,癌基因激活p53的能力涉及其转化潜能所需的相同功能,这意味着p53激活充当了对抗过度增殖信号的安全机制。此外,癌基因向p53发出信号严格需要p19(ARF)。ARF本身就是一种肿瘤抑制因子,在这种反应中充当中间介质,这一事实表明p53的肿瘤抑制活性可能源于其消除表达癌基因细胞的能力。